Racial diversity of actionable mutations in non-small cell lung cancer
- PMID: 25376516
- PMCID: PMC4305026
- DOI: 10.1097/JTO.0000000000000420
Racial diversity of actionable mutations in non-small cell lung cancer
Abstract
Introduction: Lung cancer is the leading cause of cancer-related deaths in the US. The reasons for higher incidence and poorer survival rates among black compared with white lung cancer patients have not been defined. We hypothesized that differential incidence of somatic cancer gene mutations may be a contributing factor. Previous genomic studies of non-small cell lung cancer (NSCLC) have not adequately represented black patients.
Methods: A matrix-assisted laser desorption/ionization and time-of-flight mass spectrometry approach was used to analyze tumor DNA for 214 coding mutations in 26 cancer genes previously identified in NSCLC. The samples included NSCLC from 335 white patients and 137 black patients. For 299 of these, normal matched DNA was available and analyzed.
Results: Epidermal growth factor receptor (EGFR) exon 19 deletions were only detected in women cases, with increased odds for black women compared with white women (odds ratio = 3.914, 95% confidence interval: 1.014-15.099, p = 0.048). Beyond race, variations in mutation frequencies were seen by histology. DDR2 alterations, previously described as somatic mutations, were identified as constitutional variants.
Conclusions: This study is among the largest comparing somatic mutations in black and white patients. The results point to the molecular diversity of NSCLC and raise new questions as to the importance of inherited alleles. Genomic tumor testing will benefit both populations, although the mutation spectrum appears to vary by sex, race, and histology.
Figures
Comment in
-
Racial differences in lung cancer genetics.J Thorac Oncol. 2015 Feb;10(2):230-1. doi: 10.1097/JTO.0000000000000439. J Thorac Oncol. 2015. PMID: 25611225 No abstract available.
-
Incidental Findings Implying an Inherited Cancer Syndrome from Advanced Tumor Sequencing.J Thorac Oncol. 2015 Aug;10(8):e77. doi: 10.1097/JTO.0000000000000529. J Thorac Oncol. 2015. PMID: 26200285 No abstract available.
-
In Response.J Thorac Oncol. 2015 Aug;10(8):e77-8. doi: 10.1097/JTO.0000000000000596. J Thorac Oncol. 2015. PMID: 26200286 No abstract available.
References
-
- Howlander NNA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Rulhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK. SEER Cancer Statistics Review, 1975–2008. 2011 [cited based on November 2010 SEER data submission, posted to the SEER web site, 2011; Available from: http://seer.cancer.gov/csr/1975_2008.
-
- Hardy D, Liu CC, Xia R, Cormier JN, Chan W, White A, et al. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer. 2009;115:2199–211. - PubMed
-
- Gadgeel SM, Severson RK, Kau Y, Graff J, Weiss LK, Kalemkerian GP. Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database. Chest. 2001;120:55–63. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
